Kidney Diseases Prevention. Overview The mortality rate of Nephritis, Nephrotic Syndrome, and Nephrosis (18.15 per 100,000 population) marching the 7th.

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

The National Kidney Foundations Kidney Early Evaluation Program TM The National Kidney Foundations Kidney Early Evaluation Program TM Essex-Passaic Wellness.
Di Riley Associate Director, Clinical Outcomes NCIN
Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
Renal Replacement Therapy: What the PCP Needs to Know.
Breast Cancer Reimbursement Policy in Taiwan Mao-Ting Sheen Director Bureau of National Health Insurance Department of Health, Executive Yuan November.
Technology and Expenditure Growth in Health Care Amitabh Chandra HARVARD UNIVERSITY.
 Currently 150 Million people worldwide suffering from diabetes and that number may double by the year  The prevalence of type 2 diabetes is dramatically.
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Managing depression in people with long term conditions Chris Dickens Professor of Psychological Medicine Peninsula College of Medicine and Dentistry.
National Diabetes Education Program NDEP ( ) A joint program of NIH and CDC Diabetes: The Numbers Revised.
RENAL DISEASE IN DIABETES
EPIDEMIOLOGY Epidemiology of chronic kidney injury, including prevalence and prognosis in various community groups. Screening of populations for kidney.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Provision of Preventive Services in the Complex Patient AHRQ.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
ABSTRACT SELECTING NATURAL INSULIN IMPROVES ACCESS TO COST-EFFECTIVE THERAPY OF DIABETIC PATIENTS IN THE PUBLIC SECTOR OF DAR ES SALAAM, TANZANIA Title:
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
Health Disparities of Minority Women and Diabetes Kathleen M. Rayman, Ph.D., RN Appalachian Center for Translational Research in Disparities Faculty Development.
PROPRIETARY AND CONFIDENTIAL Internal Strategic Pharmacy Programs Placemat Background 1  Prescriptions are the most frequently used health care benefit,
Bundling…..Will we survive? Thomas E. Amitrano BSN, MPA, RN.
STRATEGY FOR MANAGEMENT OF ESRD IN MOROCCO K. Soulami Service de Néphrologie CHU Ibn Rochd, Casablanca ESPN, Lyon, September 11-14, 2008.
Lincolnshire East Clinical Commissioning Group. NHS Lincolnshire East Clinical Commissioning Group authorised on 1 April 2013 Skegness & Coast, East Lindsey.
An Innovative Approach to Managing Diabetes in a Large Public Health System Donna J. Calvin, PhD, FNP-BC, CNN Post Doctoral Research Associate University.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Working Together for Stronger, Healthier Babies. Our Mission Fund Research to understand the problem and discover answers. To improve the health of babies.
DIABETES National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Section 5: Configuration of healthcare to manage CKD.
Percentage of inpatients by board cause group , Thailand Sources: Individual patient information under the Universal Coverage Scheme, Civil Servant.
Healthy People 2010 Focus Area 4
Component 1: Introduction to Health Care and Public Health in the U.S. 1.5: Unit 5: Financing Health Care (Part 2) 1.5c: Medical Expenditures: Costs Gone.
The Asheville Project “Asheville”.
Pediatric CRRT in the Developing World Dr Sidharth Kumar Sethi Pediatric Nephrology Kidney and Urology Institute Medanta-The Medicity INDIA.
Health Reform: Local Safety Net Implications Karen J. Minyard, Ph.D., Executive Director, Georgia Health Policy Center, Georgia State University.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
The Tahoe/Carson Valley Transitions in Care Collaborative “A Solution for Improved Care Management in Rural Environments”
Healthy Women Healthy Lives March 18, 2014 Healthy in America in 2014 and Beyond.
National Health Policy Conference AcademyHealth & Health Affairs Panel on Consequences of Uninsurance January 28, 2004.
The Databases: Successes and Shortcomings in Renal Replacement Therapy Since 1989 European Renal Association and European Dialysis and Transplant Association.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
Access to Quality Diabetes Education Act By Olga Ajpacaja.
The RAVE Study Renal Athersosclerotic Revascularization Evaluation Reference Tobe SW, Atri M, Perkins N, et al. Renal Athersosclerotic revascularization.
Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease Department of Nephrology R3. Yeehyung Kim.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
Overview of Diagnosed and Undiagnosed Diabetes in the United States— American Diabetes Association. Diabetes Care. 2008;31: American Diabetes.
Cardiovascular Risk: A global perspective
World Kidney Day 2016: Kidney Disease & Children
Section 1: CKD Epidemiology
Medication therapy management
Figure 11.1 Trends in ESRD expenditures,
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
Golden Rules to Keep Kidneys Healthy
Cindy Hatton President & CEO Susan Levitt V.P. Clinical Services/COO
Lead for the quantitative evaluation
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Chapter 9: Healthcare Expenditures for Persons with ESRD
St. Louis County Diabetes prevention Programming
Need to Know! Screening and Diagnosis of Kidney Disease in Diabetes
Volume 83, Issue 3, Pages (March 2013)
End-stage renal disease prevention strategies in Latin America
The Future Use of Technology in Outpatient Care Using the Computerized Patient Record to Implement Principles of Disease Management: Focus on the.
Healthcare Policies in GCC: Challenges and Future Directions:
Chapter 9: Healthcare Expenditures for Persons with ESRD
Chronic Kidney Disease
Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.
American Journal of Kidney Diseases
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Megan Eguchi, MPh Sana karam, md, phd
Worldwide incidence of ESRD figure 12.1, per million population
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Presentation transcript:

Kidney Diseases Prevention

Overview The mortality rate of Nephritis, Nephrotic Syndrome, and Nephrosis (18.15 per 100,000 population) marching the 7th leading cause of death in 2001 In the end of 2000, there were 30,129 ESRD (End Stage Renal Disease) patients in Taiwan the ESRD prevalence (1352 per million population) and incidence (311 per million population) are both the second highest in the world

Prevalence of ESRD

Incidence of ESRD

Overview Why the ESRD prevalence and incidence are so high in Taiwan? –the execution of the National Health Insurance Act –The novel medical technique increases the survival –The misuse of the nephrotoxic drugs: NSAID, herbs –The late referral to the nephrologist The average health expenditure of ESRD is about NT$18 billion

Patient Benefit Claims by Category of Major Illness/injury in 2001

Overview Factors that affect spending for ESRD patient care –Patient’s clinical requirements –Pre-ESRD education –Referral timing –Choice of modality –Center or home therapy –Reimbursement

Strategy Strengthen the education program of kidney disease prevention (esp. pre-ESRD education) Construct the health education system for kidney disease prevention Follow up the patient’s therapeutic outcome by integrating the health care providers to prevent the aggravation of renal function and lower the incidence of ESRD

Strategy Strengthen the prevention of diabetes and hypertension to avoid renal disease complication Pursuing the basic research for kidney disease prevention as the reference of policy making